
Naveen Pemmaraju/X
May 19, 2025, 11:14
Naveen Pemmaraju and Gaby Hobbs Discuss Advancing Disease Modification in MPNs
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center, posted on X:
“Always lovely to chat with Dr Gaby Hobbs about one of our mutual passion areas: improving disease modification and considering new response criteria in MPNs!”
More posts featuring Naveen Pemmaraju.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 19, 2025, 11:14
May 19, 2025, 10:58
May 19, 2025, 10:26
May 19, 2025, 10:14
May 19, 2025, 10:12
May 19, 2025, 10:02
May 19, 2025, 10:00